Core Laboratories NV (CLB)

Currency in USD
12.22
-0.21(-1.69%)
Real-time Data·
Advertisement
CLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.1112.33
52 wk Range
9.7920.36
Key Statistics
Prev. Close
12.43
Open
12.33
Day's Range
12.11-12.33
52 wk Range
9.79-20.36
Volume
46.06K
Average Volume (3m)
843.15K
1-Year Change
17.0662%
Book Value / Share
5.92
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.50
Upside
+26.84%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Core Laboratories NV News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
1 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 15.50
(+26.84% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Hold12.00-1.72%13.00Maintain10/10/2025

Core Laboratories NV Earnings Call Summary for Q2/2026

  • Core Labs posted Q2 2026 GAAP EPS of $0.13, missing the $0.30 forecast by 56.7%; revenue rose 2% sequentially to $124.6M but fell 4% year-over-year.
  • EBIT ex-items improved to $9.4M from $6.6M in Q1; free cash flow turned positive at $3.1M as the company repurchased 214K shares for $2.7M.
  • Middle East and Russia-Ukraine conflicts continue disrupting operations; global cargo movements down 16%, delaying projects and reducing assay business.
  • Q3 2026 guidance: revenue $128.5M-$135.5M, EPS $0.12-$0.20 (midpoint $0.16); management expects offshore exploration rebound late 2026 into 2027.
  • CEO Bruno emphasized technology investments in InPulse, tracer diagnostics, and CT analysis; Q4 guidance withheld due to geopolitical uncertainty.
Last Updated: 30/07/2026, 14:40
Read Full Transcript

Earnings

Latest Release
29/07/2026
EPS / Forecast
0.13 / 0.30
Revenue / Forecast
124.6M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.52%
Dividend Yield
0.33%
Industry Median 1.36%
Annualised payout
0.04
Paid quarterly
5-Years Growth
-
Growth Streak

Compare CLB to Peers and Sector

Metrics to compare
CLB
Peers
Sector
Relationship
P/E Ratio
22.9x36.6x5.7x
PEG Ratio
−1.46−0.010.00
Price/Book
2.0x2.1x1.1x
Price / LTM Sales
1.1x2.1x1.4x
Upside (Analyst Target)
8.6%8.4%25.8%
Fair Value Upside
Unlock6.1%6.1%Unlock

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
21.80M47.52%266.44M
Other Institutional Investors
26.77M52.48%327.19M
Public Companies & Retail Investors
0.000.00%0.00
Total
48.58M100.00%593.63M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ariel Investments, LLC28.70%13,170,388160,942
Ariel Investment Trust - Ariel Fund11.79%5,411,35166,127

People Also Watch

26.32
MD
+0.67%
183.39
LSTR
+3.18%
17.77
WWW
-2.36%
29.93
INVX
-0.70%

FAQ

What Is the Core Laboratories (NYSE: CLB) Share Price Today?

The Core Laboratories stock price today is 12.22 USD.

What Stock Exchange Does Core Laboratories (CLB) Trade On?

Core Laboratories is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Core Laboratories?

The stock symbol (also called a 'ticker') for Core Laboratories is "CLB."

Does Core Laboratories Pay Dividends? What’s The Current CLB Dividend Yield?

Yes, CLB Pays Dividends to its Shareholders. The current Core Laboratories dividend yield is 0.33%.

What Is the Current Core Laboratories Market Capitalisation?

As of today, Core Laboratories (NYSE: CLB) market cap is 560.71M USD.

What Is Core Laboratories's (CLB) Earnings Per Share (TTM)?

The Core Laboratories EPS is currently 0.52 (Trailing Twelve Months).

When Is the Next Core Laboratories Earnings Date?

Core Laboratories's next earnings report will be released on 28/10/2026.

Is CLB a Buy or Sell From a Technical Analyst Perspective?

Based on today's Core Laboratories moving averages and other technical indicators, the daily buy/sell signal for CLB stock is Strong Buy.

How Many Times Has Core Laboratories Stock Split?

Core Laboratories has split 2 times. (See the CLB stock split history page for full effective split date and price information.)

How Many Employees Does Core Laboratories Have?

Core Laboratories has 3300 employees, based on their latest Companies House report.

What is the current trading status of Core Laboratories (NYSE: CLB)?

As of 12/08/2026, Core Laboratories (CLB) is trading at a share price of 12.22 USD, with a previous close of 12.43 USD. The stock has fluctuated within a day range of 12.11 USD to 12.33 USD, while its 52-week range spans from 9.79 USD to 20.36 USD.

What Is Core Laboratories (CLB) Price Target According to Analysts?

The average 12-month price target for Core Laboratories is 15.50 USD, with a high estimate of 22 USD and a low estimate of 11 USD. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +26.84% Upside potential.

What Is the CLB Premarket Price?

CLB's last pre-market stock price is 12.52 USD. The pre-market share volume is 330.00, and the stock has decreased by 0.09, or 0.72%.

What Is the CLB After Hours Price?

CLB's last after hours stock price is 12.54 USD, the stock has decreased by 0.11, or 0.90%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.